China Veterinary Biological Products Industry Operation Prospect and Investment Planning Research Report 2023 2030
Publisher]: Zhongying Xinhe Research Network.
The content part is abridged and detailed, please refer to the full information published by Zhongying Xinhe Research Network!】
Chapter 1: Overview of the market development of China's veterinary biological products industry.
1.1 Overview of the veterinary biological products industry.
1.1.1 Industry concepts and definitions.
1.1.2 Classification of major products in the industry.
1.1.3 Introduction to the industry chain.
1) Panorama of the industrial chain.
2) Upstream analysis of the veterinary biological products industry.
3) Downstream analysis of the veterinary biological products industry.
1.2 Analysis of the development environment of the veterinary biological products industry.
1.2.1 Analysis of the economic environment of the veterinary biological products industry.
1) The current situation and trend of global economic development.
2) The current situation and trend of China's economic development.
1.2.2 Analysis of the political environment of the veterinary biological products industry.
1) Industry authorities and related organizations.
2) Summary and interpretation of industry-related policies.
3) Analysis of the industry regulatory system.
1.2.3 Analysis of the social environment of the veterinary biological products industry.
1) Analysis of disposable income and expenditure level of Chinese residents.
2) The development of animal husbandry drives the demand for vaccines.
3) Animal diseases hit the market for veterinary biological products.
1.2.4 Technical environment analysis of the veterinary biological products industry.
1) Application of cell suspension culture technology.
2) Application of low serum and serum-free media.
3) Application of novel vaccine adjuvants.
4) Application of antigen purification technology.
Chapter 2: Analysis of the current development status of China's veterinary biological products industry.
2.1. Analysis of the development status of the veterinary drug industry.
2.1.1 Analysis of the overall development of the veterinary drug industry.
1) The overall development of the foreign veterinary drug industry.
2) The overall development of the domestic veterinary drug industry.
2.1.2 Market size analysis of the veterinary drug industry.
1) Analysis of foreign veterinary drug market.
2) Analysis of China's veterinary drug market.
3) The overall research and development of veterinary drugs.
2.2 Analysis of the development status of the veterinary biological products industry.
2.2.1 Analysis of the development of the veterinary biological products industry.
2.2.2 Analysis of supply and demand in the veterinary biological products industry.
1) ** Situation analysis.
2) Demand analysis.
2.2.3 Analysis of typical enterprises in the veterinary biological products industry.
2.2.4 Analysis of the development characteristics of the veterinary biological products industry.
1) Analysis of the characteristics of the industry.
2) Summary of the current situation of industry development.
2.3 Structural analysis of veterinary biological products.
2.3.1 Composition of veterinary biological products.
2.3.2 Composition of veterinary biological products.
2.4 Analysis of the research and development of veterinary biological products.
2.4.1 New registration of veterinary biological products.
2.4.2 R&D status of veterinary biological products.
2.5 Analysis of the operating benefits of the veterinary biological products industry.
2.5.1 Analysis of the cost structure of the veterinary biological products industry.
2.5.2 Changes in the market for veterinary biological products.
2.5.3 Analysis of operating profit of veterinary biological products industry.
2.5.4 Analysis of the development capacity of the veterinary biological products industry.
Chapter 3: Market Competitiveness Analysis of Domestic and Foreign Veterinary Biological Products Industry.
3.1 Analysis of competition in the international veterinary biological products industry.
3.1.1 Overall competition analysis of the international veterinary biological products industry.
3.1.2 Regional competition pattern of the international veterinary biological products industry.
3.1.3 The competitive landscape of enterprises in the international veterinary biological products industry.
3.2 Analysis of the competitive landscape of China's veterinary biological products industry.
3.2.1 The competitive landscape of subdivided products in China's veterinary biological products industry.
3.2.2 The competitive landscape of enterprises in China's veterinary biological products industry.
3.3 Analysis of the five forces model of China's veterinary biological products industry.
3.3.1. Upstream bargaining power.
3.3.2. Bargaining power of downstream customers.
3.3.3 Competition among incumbents.
3.3.4 Threats from potential entrants in the industry.
3.3.5 Competitive analysis of industry alternatives.
3.3.6 Summary of the Five Forces Model of the Industry.
Chapter 4: Segmented Product Analysis of China's Veterinary Biological Products Industry.
4.1 Market prospect analysis of veterinary biological products for prevention.
4.1.1 Structural analysis of veterinary biological products for prevention.
4.1.2 Analysis of the development status of veterinary biological products for prevention.
1) The construction of animal epidemic prevention system.
2) The development process of veterinary vaccines.
3) The current status of veterinary vaccine development and development.
4.1.3 Market supply and demand analysis of veterinary biological products for prophylaxis.
1) Production and sales of major enterprises.
2) Market size analysis.
3) Market size analysis of major application markets.
4) Batch issuance of veterinary vaccines.
5) Import and export market analysis.
4.1.4 Analysis of typical enterprises of veterinary biological products for prevention.
4.1.5 Market prospect of veterinary biological products for prevention**.
4.2 **Analysis of the market prospect of veterinary biological products.
4.2.1 **Structural analysis of veterinary biological products.
4.2.2 **Analysis of the development status of veterinary biological products.
4.2.3 **Analysis of supply and demand in the veterinary biological products market.
4.2.4 **Analysis of typical enterprises with veterinary biological products.
4.2.5 **Market prospect of veterinary biological products**.
4.3 Market prospect analysis of veterinary biological products for diagnostic use.
4.3.1 Structural analysis of veterinary biological products for diagnostic use.
4.3.2 Analysis of the development status of veterinary biological products for diagnostic use.
1) Development of veterinary biological products for diagnostic use.
4.3.3 Market supply and demand analysis of veterinary biological products for diagnostic use.
1) New registrations.
2) Product category analysis.
3) Market demand analysis.
4.3.4 Analysis of typical enterprises of veterinary biological products for diagnosis.
4.3.5 Market outlook for veterinary biological products for diagnostic use**.
Chapter 5: Investment Potential in Key Regions of China's Veterinary Biological Products Industry.
5.1 Analysis of investment potential of veterinary biological products industry in Shandong.
5.1.1 Development conditions for the veterinary biological products industry in Shandong Province.
5.1.2 Development status of veterinary biological products industry in Shandong Province.
5.1.3 Development of enterprises in the veterinary biological products industry in Shandong Province.
5.1.4 Development prospects of veterinary biological products industry in Shandong Province.
5.2 Analysis of investment potential of veterinary biological products industry in Zhejiang Province.
5.2.1 Development conditions of veterinary biological products industry in Zhejiang Province.
5.2.2 Development status of veterinary biological products industry in Zhejiang Province.
5.2.3 Development of enterprises in the veterinary biological products industry in Zhejiang Province.
5.2.4 Development prospects of veterinary biological products industry in Zhejiang Province.
5.3 Analysis of the investment potential of the veterinary biological products industry in Guangdong Province.
5.3.1 Development conditions for the veterinary biological products industry in Guangdong Province.
5.3.2 Development status of veterinary biological products industry in Guangdong Province.
5.3.3 Development of enterprises in the veterinary biological products industry in Guangdong Province.
5.3.4 Development prospects of veterinary biological products industry in Guangdong Province.
5.4 Analysis of investment potential of veterinary biological products industry in Sichuan Province.
5.4.1 Development conditions of veterinary biological products industry in Sichuan Province.
5.4.2 Development status of veterinary biological products industry in Sichuan Province.
5.4.3 Development of enterprises in the veterinary biological products industry in Sichuan Province.
5.4.4 Development prospects of veterinary biological products industry in Sichuan Province.
5.5 Analysis of investment potential of veterinary biological products industry in Jiangsu Province.
5.5.1 Development conditions for the veterinary biological products industry in Jiangsu Province.
5.5.2 Development status of veterinary biological products industry in Jiangsu Province.
5.5.3 Supply and demand of veterinary biological products industry in Jiangsu Province.
5.5.4 Development prospects of veterinary biological products industry in Jiangsu Province.
Chapter 6: Business Analysis of Key Companies in China's Veterinary Biological Products Industry.
6.1 The overall development of enterprises in China's veterinary biological products industry.
6.2 Business analysis of key enterprises in China's veterinary biological products industry.
6.2.1 China Animal Husbandry Industrial Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.2 Tianjin Ruipu Biotechnology Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.3 Pleco Bioengineering Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.4 Jinyu Biotechnology Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Analysis of enterprise sales model.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.5 Tiankang Biotech shares***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.6 Shanghai Haili Biotechnology Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.7 Jinhe Biotechnology Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.8 Shandong Lukang Pharmaceutical Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
6) Analysis of the latest development trends of the enterprise.
6.2.9 Wuhan Keqian Biological Co., Ltd. ***
1) Brief analysis of enterprise development.
2) Analysis of business conditions.
3) Analysis of enterprise business structure.
4) Enterprise sales network analysis.
5) Analysis of the advantages and disadvantages of the company's operating conditions.
Chapter 7: Development Prospects and Investment Opportunities of China's Veterinary Biological Products Industry.
7.1 Development prospects and trends of China's veterinary biological products industry.
7.1.1 Analysis of the development prospect of the veterinary biological products industry.
7.1.2 Analysis of the development trend of the veterinary biological products industry.
1) The development direction of veterinary vaccine products.
2) The scale of the breeding industry will promote the centralization of the veterinary drug industry.
3) The scale effect and brand effect of large enterprises are becoming increasingly prominent.
7.2 Investment barriers and risk analysis of China's veterinary biological products industry.
7.2.1 Analysis of entry barriers in the veterinary biomass products industry.
1) Qualification barriers.
2) Financial barriers.
3) Technical barriers.
4) Marketing network and technical service system barriers.
5) Production process and quality control barriers.
6) Human resource barriers.
7.2.2. Early warning of investment risks in the veterinary biological products industry.
1) Policy risk.
2) Technical risks.
3) Product quality risk.
4) Competition risk.
5) Macroeconomic fluctuation risk.
6) Risks associated with the industry.
7.3 Zhongying's investment advice on the veterinary biological products industry.
7.3.1 Investment opportunities in China's veterinary biological products industry.
1) Investment opportunities in animal vaccines.
2) Diagnostic product investment opportunities.
3) Investment opportunities in animal preparations.
4) Investment opportunities in animal APIs.
7.3.2 Investment value of China's veterinary biological products industry.
7.3.3 Investment suggestions for China's veterinary biological products industry.
Table of Contents of Charts. Figure 1: National economic classification to which the veterinary biological products industry belongs.
Figure 2: Introduction to the main product categories of veterinary biological products.
Figure 3: The upstream and downstream chains of China's livestock and poultry breeding industry.
Figure 4: Changes in the output value of China's animal husbandry from 2016 to 2023 (unit: 100 million yuan).
Figure 5: Changes in the national pig inventory from 2016 to 2023 (unit: 10,000 heads).
Figure 6: Changes in the national cattle herd from 2017 to 2023 (unit: 10,000 heads).
Figure 7: Changes in poultry slaughter in China from 2015 to 2023 (unit: 100 million).
Figure 8: Trends in U.S. gross domestic product (USD) from 2017 to 2023 (trillions, %)
Chart 9: Quarterly year-on-year change in Eurozone GDP from 2017 to 2023 (in %)
Chart 10: Changes in Japan's GDP from 2010 to 2023 (in %)
Exhibit 11: Global economic growth** (in %) of the world's major economies, 2021-2024
Figure 12: GDP trend and year-on-year growth rate from 2014 to 2023 (unit: trillion yuan, %)
Figure 13: Changes in national fixed asset investment (excluding rural households) from 2014 to 2023 (unit: trillion yuan).
Exhibit 14: China's GDP by institution** (in %), 2024
Figure 15: Authorities in China's veterinary biological products industry and their related responsibilities.
Exhibit 16: Summary of industry standards for veterinary biological products as of 2023.
Exhibit 17: Veterinary biological products industry policies and development plans as of 2023.
Exhibit 18: Summary of key points of the Animal Epidemic Prevention Law.
Exhibit 19: Summary of the main regulatory regimes in the veterinary biological products industry.
Figure 20: Per capita disposable income of urban and rural residents in China, 2012-2023 (unit: yuan, %)
Figure 21: Per capita consumption expenditure of Chinese residents from 2015 to 2023 (unit: RMB).
Exhibit 22: Changes in the market size of the global veterinary drug industry from 2018 to 2023 (unit: USD billion).
Exhibit 23: Product structure of foreign veterinary drug market (unit: %)
Figure 24: Sales and growth rate of China's veterinary drug industry from 2015 to 2023 (unit: 100 million yuan, %)
Exhibit 25: Biologics Market Share Distribution by Product Category (Unit: %)
Figure 26: Statistics of new veterinary drug registrations in China from 2014 to 2023 (unit: units).
Figure 27: Annual increase in the number of veterinary biological products enterprises in China from 2016 to 2023 (unit: households).
Figure 28: 2016-2023 sales of veterinary biological products and** (unit: 100 million yuan).
Exhibit 29: Analysis of typical companies in the veterinary biological products industry.
Figure 30: Seasonal depiction of animal disease occurrence.
Figure 31: Summary of the development status of the veterinary biological products industry.
Exhibit 32: Animal Vaccines Market Share Distribution by Applicable Object (Unit: %)
Figure 33: Domestic veterinary biological products by compulsory immunization score (unit: %), 2016-2023
Figure 34: Number of newly registered veterinary biological products in China from 2015 to 2023 (unit: units).
Figure 35: R&D funding for veterinary biological products in China from 2018 to 2023 (unit: 100 million yuan).
Chart 36: Proportion of raw material procurement amount of Wuhan Keqian Biological Co., Ltd. (unit: %)
Figure 37: Wuhan Huisheng Biotechnology Co., Ltd.*** Proportion of raw material procurement amount (unit: %)
Exhibit 38: Changes in the procurement of vaccines in some provinces.
Exhibit 39: 2023 Animal Vaccine Tenders in Selected Regions**.
Figure 40: 2017-2023 trend of net profit of major enterprises of veterinary biological products in China (unit: 100 million yuan).
Figure 41: 2017-2023 Trend of Revenue Growth Rate of Major Veterinary Biological Products Enterprises in China (Unit: %)
Figure 42: 2017-2023 trend of net profit growth rate of major enterprises of veterinary biological products in China (unit: %)
Exhibit 43: Summary of products by international veterinary biologics manufacturers.
Exhibit 44: Top 20 global animal health companies in FY2023 (unit: US$100 million, %)
Exhibit 45: Structure of newly registered veterinary biopharmaceuticals in China in 2023 (unit: %)
Figure 46: Distribution of competitive echelon of domestic veterinary biological products industry.
Figure 47: Operating income of major domestic veterinary biological products enterprises in 2023 (unit: 100 million yuan).
Exhibit 48: Bargaining power of the upstream of the veterinary biological products industry.
Exhibit 49: Bargaining power of downstream customers in the veterinary biologics industry.
Figure 50: Concentration of China's veterinary biological products industry from 2017 to 2023 (unit: 100 million yuan, %)
Figure 51: Analysis of the Five Forces Model of China's Veterinary Biological Products Industry.
Figure 52: Types of veterinary biological products for preventive use.
Figure 53: Construction of animal epidemic prevention supervision system.
Figure 54: Compulsory immunization of animal diseases in China from 2008 to 2023.
Exhibit 55: Analysis of the development of animal vaccines in China.
Figure 56: Technical level of Chinese veterinary vaccine companies.
Figure 57: Technology trends in the veterinary vaccine industry.
Chart 58: 2023 China Animal Husbandry Industrial Co., Ltd. *** product sales volume (unit: 100 million ml 100 million heads 100 million feathers, %)
Figure 59: Production and sales of veterinary vaccines of biological shares in 2023 (unit: 10,000 ml and 10,000 servings).
Figure 60: Production and sales of veterinary vaccines in 2023 (unit: 10,000 ml, 10,000 heads, 10,000 feathers).
Figure 61: Production and sales of Pleco veterinary vaccines in 2023 (unit: 100 million milliliters, 100 million heads, 100 million feathers, 10,000 liters, 10,000 kilograms).
Figure 62: Market size and growth rate of China's preventive veterinary biological products from 2015 to 2023 (unit: 100 million yuan, %)
Figure 63: 2015-2023 China swine biological products market size and ** (unit: 100 million yuan).
Figure 64: China's poultry biological products market size from 2015 to 2023 (unit: 100 million yuan).
Exhibit 65: Ranking of domestic veterinary vaccine batches issued in 2023 (by product).
Exhibit 66: Ranking of domestic veterinary vaccine batches issued in 2023 (by company).
Exhibit 67: Ranking of Batches of Imported Veterinary Vaccines Issued in 2023 by Product
Figure 68: Ranking of batches issued for imported veterinary vaccines in 2023 (by company).
Figure 69: Import and export of China's veterinary vaccine industry from 2018 to 2023 (unit: ton).
Figure 70: Import and export of China's veterinary vaccine industry from 2018 to 2023 (unit: US$ 100 million).
Exhibit 71: Imports of China's veterinary vaccine industry from 2018 to 2023 (unit: ton, US$ 100 million).
Exhibit 72: Exports of China's veterinary vaccine industry from 2018 to 2023 (unit: tons, US$ 100 million).
Exhibit 73: Structure of China's imports and exports of veterinary biological products for preventive use (by value) (unit: %), 2023
Exhibit 74: Competitive Landscape Analysis of Veterinary Biological Products for Preventive Use in China (Unit: %)
Figure 75: China's prophylactic veterinary biological products market size** (unit: 100 million yuan) from 2023 to 2030
Exhibit 76: **Species of veterinary biological products.
Exhibit 77: Application analysis of veterinary biologics.
Exhibit 78: **Manufacturers of veterinary biological products.
Figure 79: Number of newly registered veterinary drugs for diagnostic biological products in China from 2017 to 2023 (unit: units).
Exhibit 80: Newly registered veterinary drugs for detection in 2023.
Exhibit 81: Veterinary diagnostic reagent product segment.
Figure 82: Manufacturers of veterinary biological products for diagnostic use.
Figure 83: Development characteristics of veterinary biological products for diagnostic use.
Figure 84: Development status of animal husbandry in Shandong Province in 2023 (unit: 10,000 heads, 10,000 animals, %)
Exhibit 85: Rating of veterinary drug manufacturers in Shandong Province in 2023 (unit: home, %)
Figure 86: Introduction of representative enterprises in the veterinary biological products industry in Shandong Province.
Figure 87: Development status of animal husbandry in Zhejiang Province in 2023 (unit: 10,000 tons, 10,000 heads, 10,000 animals, %)
Figure 88: The number of new enterprises in the veterinary biological products industry in Zhejiang Province from 2016 to 2023 (unit: households).
Figure 89: Introduction of representative enterprises in the veterinary biological products industry in Zhejiang Province.
Figure 90: Development status of animal husbandry in Guangdong Province in 2023 (unit: 10,000 heads, 100 million animals, %)
Figure 91: The number of new enterprises in the veterinary biological products industry in Guangdong Province from 2016 to 2023 (unit: households).
Exhibit 92: Introduction of representative enterprises in the veterinary biological products industry in Guangdong Province.
Figure 93: Development status of animal husbandry in Sichuan Province in 2023 (unit: 10,000 heads, 10,000 animals, %)
Figure 94: The number of new enterprises in the veterinary biological products industry in Sichuan Province from 2016 to 2023 (unit: households).
Figure 95: Introduction of representative enterprises in the veterinary biological products industry in Sichuan Province.
Figure 96: Development status of animal husbandry in Jiangsu Province in 2023 (unit: 10,000 heads, 100 million animals, %)
Figure 97: The number of new enterprises in the veterinary biological products industry in Jiangsu Province from 2016 to 2023 (unit: households).
Figure 98: Introduction of representative companies in the veterinary biological products industry in Jiangsu Province.
Exhibit 99: Analysis of the main economic indicators of representative enterprises in China's veterinary biological products industry in 2023 (unit: 100 million yuan, %)
Chart 100: China Animal Husbandry Industrial Co., Ltd. *** basic information table.
Chart 101: Block diagram of the property rights and control relationship between China Animal Husbandry Industrial Co., Ltd. and the actual controller as of 2023 (unit: %)
Chart 102: Analysis of the main economic indicators of China Animal Husbandry Industrial Co., Ltd. from 2017 to 2023 (unit: 100 million yuan).
Chart 103: 2017-2023 China Animal Husbandry Industrial Co., Ltd. *** profitability analysis (unit: %)
Chart 104: 2017-2023 China Animal Husbandry Industrial Co., Ltd. *** operational capacity analysis (unit: times).
Chart 105: 2017-2023 China Animal Husbandry Industrial Co., Ltd. *** solvency analysis (unit: %, times).
Chart 106: 2017-2023 China Animal Husbandry Industrial Co., Ltd. *** development capacity analysis (unit: %)
Chart 107: 2023 China Animal Husbandry Industrial Co., Ltd. *** product structure (unit: %)
Chart 108: Distribution of sales areas of China Animal Husbandry Industrial Co., Ltd. in 2023 (unit: %)
Chart 109: Analysis of the advantages and disadvantages of China Animal Husbandry Industrial Co., Ltd.
Chart 110: Basic information table of Tianjin Ruipu Biotechnology Co., Ltd.
Exhibit 111: Block diagram of the property rights and control relationship between Tianjin Rip Biotechnology Co., Ltd. *** and the actual controller as of the end of 2023 (unit: %)
Chart 112: Analysis of the main economic indicators of Tianjin Ruipu Biotechnology Co., Ltd. from 2017 to 2023 (unit: 100 million yuan).
Exhibit 113: 2017-2023 Tianjin Ruipu Biotechnology Co., Ltd.*** profitability analysis (unit: %)
Chart 114: 2017-2023 Tianjin Ruipu Biotechnology Co., Ltd.*** Operational Capability Analysis (Unit: Times).
Chart 115: 2017-2023 Tianjin Ruipu Biotechnology Co., Ltd. *** solvency analysis (unit: %, times).
Chart 116: 2017-2023 Tianjin Ruipu Biotechnology Co., Ltd.*** development capacity analysis (unit: %)
Exhibit 117: Tianjin Ruipu Biotechnology Co., Ltd.*** key product introduction.
Chart 118: 2023 Tianjin Rip Biotechnology Co., Ltd.*** vaccine product structure analysis (unit: %)
Chart 119: 2023 Tianjin Ruipu Biotechnology Co., Ltd.*** Main business by region (unit: %)
Chart 120: Analysis of the advantages and disadvantages of Tianjin Ruipu Biotechnology Co., Ltd.